Zalcitabine (2′,3′-dideoxycytidine; ddC) is an inhibitor of HIV reverse transcriptase. The intracellular metabolism of ddC in peripheral blood mononuclear cells (PBMCs), U937 cells and Molt 4 cells were investigated, and phosphate metabolites were determined by on-line radiometric HPLC. Comparable levels of all three ddC phosphate metabolites were formed in PHA-stimulated PBMCs, U937 cells and Molt 4 cells.
Zidovudine (ZDV), didanosine (ddl) and stavudine (d4T) had no significant effect on ddC (0.06μM) phosphorylation in PBMCs whereas the endogenous nucleoside, cytidine decreased phosphorylation in a concentration-dependent manner (e.g. 41 % inhibition of total phosphate formation at 6μM cytidine, 85% inhibition at 60μM).
The cytotoxic anticancer drug doxorubicin caused a decrease in ddC phosphorylation in U937/Molt 4 cells (e.g. 56% inhibition of total phosphate formation in U937 cells; 55% in Molt 4 cells at a doxorubicin concentration of 60μM), whilst the antiviral agent ribavirin exhibited no inhibitory effects.
AhluwaliaG.CooneyD.A.MitsuyaH.FridlandA.FloraK.P.HaoZ.DalaiM.BroderS., and JohnsD.G. (1987) Initial studies on the cellular pharmacology of 2′,3′-dideoxyinosine, an inhibitor of HIV infectivity. Biochem Pharmacol36: 3797–3800.
2.
AugustE.M.MarongiuM.E.LinT.-S., and PrusoffW.H. (1988) Initial studies on the cellular pharmacology of 3′-deoxythymidin-2′-ene (d4T): a potent and selective inhibitor of human immunodeficiency virus. Biochem Pharmacol37: 4419–4422.
3.
BabaM.PauwelsFt.BalzariniJ.HerdewijnP.De ClercqE., and DesmyterJ. (1987) Ribavirin antagonizes inhibitory effects of pyrimidine 2′,3′-dideoxynucleosides but enhances inhibitory effects of purine 2′,3′-dideoxynucleosides on replication of human immunodeficiency virus in vitro. Antimicrob Agents Chemother31: 1613–1617.
4.
BalzariniJ.PauwelsR.BabaM.HerdewijnP.De ClercqE.BroderS., and JohnsD.G. (1988) The in vitro and in vivo anti-retrovirus activity and intracellular metabolism of 3′-azido-2′,3′-dideoxythymidine and 2′,3′-dideoxycytidine are highly dependent on cell species. Biochem Pharmacol37: 897–903.
5.
CammackN.RouseP.MarrC.L.P.ReidP.J.BoehmeR.E.CoatesJ.A.V.PennC.R., and CameronJ.M. (1992) Cellular metabolism of (-) enantiomeric 2′-deoxy-3′-thiacytidine. Biochem Pharmacol43: 2059–2064.
6.
ChenC-H., and ChengY-C. (1989) Delayed cytotoxicity and selective loss of mitochondrial DNA in cells treated with the anti-human immunodeficiency virus compound 2′,3′-dideoxycytidine. J Biol Chem264: 11934–11937.
7.
CooneyD.A.DalalM.MitsuyaH.McMahonJ.B.NadkarniM.BalzariniJ.BroderS., and JohnsD.G. (1986) Initial studies on the cellular pharmacology of 2′,3′-dideoxycytidine, an inhibitor of HTLV-III infectivity. Biochem Pharmacol35: 2065–2068.
8.
FurmanP.A.FyfeJ.A.St ClairM.H.WeinholdK.RideoutJ.L.FreemanG.A.Nusinoff LehrmanS.BolognesiD.P.BroderS.MitsuyaH., and BarryD.W. (1986) Phosphorylation of 3′-azido-3′-deoxythymidine and selective interaction of the 5′-triphosphate with human immunodeficiency virus reverse transciptase. Proc Natl Acad Sci USA83: 8333–8337.
9.
GaoW.-Y.ShirasakaT.JohnsD.G.BroderS., and MitsuyaH. (1993) Differential phosphorylation of azidothymidine, dideoxycytidine and dideoxyinosine in resting and activated peripheral blood mononuclear cells. J Clin Invest91: 2326–2333.
10.
GaoW.-Y.AgbariaR.DriscollJ.S., and MitsuyaH. (1994) Divergent anti-human immunodeficiency virus activity and anabolic phosphorylation of 2′,3′-dideoxynucleoside analogs in resting and activated human cells. J Biol Chem269: 12633–12638.
11.
HaoZ.StoweE.E.AhluwaliaG.BakerD.C.HebblerA.K.ChisenaC.MusserS.M.KelleyJ.A.PernoC.-F.JohnsD.G., and CooneyD.A. (1993) Characterization of 2′,3′-dideoxycytidine diphosphocholine and 2′,3′-dideoxycytidine diphosphoethanolamine. Prominent phosphodiester metabolites of the anti-HIV nucleoside 2′,3′-dideoxycytidine. Drug Metab Dispos21: 738–744.
12.
HoggardP.G.VealG.J.WildM.J.BarryM.G., and BackD.J. (1995) Drug interactions with zidovudine phosphorylation in vitro. Antimicrob Agents Chemother39: 1376–1378.
13.
MeriganT.C.SkowronG.BozzetteS.A.RichmanD.UttamchandaniR.FischlM.SchooleyR.HirschM.SooW.PettinelliC.SchaumburgH., and the ddC Study Group of the AIDS Clinical Trials Group. (1989) Circulating p24 antigen levels and responses to dideoxycytidine in human immunodeficiency virus (HIV) infections. A phase I and II study. Ann Intern Med110: 189–194.
14.
MitsuyaH., and BroderS. (1986) Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2′,3′-dideoxynucleosides. Proc Natl Acad Sci USA83: 1911–1915.
15.
MorseG.D.SheltonM.J., and O'DonnellA.M. (1993) Comparative pharmacokinetics of antiviral nucleoside analogues. Clin Pharmacokinet24: 101–123.
16.
MukherjiE.AuJ.L.-S., and MathesL.E. (1994) Differential antiviral activities and intracellular metabolism of 3′-azido-3′-deoxythymidine and 2′,3′-dideoxyinosine in human cells. Antimicrob Agents Chemother38: 1573–1579.
17.
MurphyR. (1995) Clinical aspects of human immunodeficiency virus disease: clinical rationale for treatment. J Infect Dis171: S81–S87.
18.
PlagemannP.G.W.WohlhueterR.M., and WoffendinC. (1988) Nucleoside and nucleobase transport in animals cells. Biochim Biophys Acta947: 405–443.
19.
SaagM.S. (1994) What to do when zidovudine fails. N Engl J Med330: 706–707.
20.
StarnesM.C., and ChengY.-C. (1987) Cellular metabolism of 2′,3′-dideoxycytidine, a compound active against human immunodeficiency virus in vitro. J Biol Chem262: 988–991.
21.
TörnevikY.JacobssonB.BrittonS., and ErikssonS. (1991) Intracellular metabolism of 3′-azidothymidine in isolated human peripheral blood mononuclear cells. AIDS Res Human Retroviruses7: 751–759.
22.
VealG.J.WildM.J.BarryM.G., and BackD.J. (1994) Effects of dideoxyinosine and dideoxycytidine on the intracellular phosphorylation of zidovudine in human mononuclear cells. Br J Clin Pharmacol38: 323–328.
23.
VogtM.W.HartshornK.L.FurmanP.A.ChouT.-C.FyfeJ.A.ColemanL.A.CrumpackerC.SchooleyR.T., and HirschM.S. (1987) Ribavirin antagonizes the effect of azidothymidine on HIV replication. Science235: 1376–1379.
24.
WaqarM.A.EvansM.J.ManlyK.F.HughesR.G., and HubermanJ.A. (1984) Effects of 2′,3′-dideoxynucleosides on mammalian cells and viruses. J Cell Physiol121: 402–408.
25.
YarchoanR.PernoC.-F.ThomasR.V.KleckerR.W.AllainJ.-P.WillsR.J.McAteeN.FischlM.A.DubinskyR.McNeelyM.C.MitsuyaH.PludaJ.M.LawleyT.J.LeutherM.SafaiB.CollinsJ.M.MyersC.E., and BroderS. (1988) Phase I studies of 2′,3′-dideoxycytidine in severe human immunodeficiency virus as a single agent and alternating with zidovudine (AZT). LancetI: 76–81.
